Drooid Logo
Back to today’s briefing

Story perspectives

FTC, States File Contempt Motion Over Shkreli Pharma Ban

By Drooid · · How we work

5 1 Full Breakdown

1 of 1

Story summary
  • The FTC and several states filed a contempt motion against Martin Shkreli for violating his 2022 pharma ban.
  • The 2022 order bars him from owning or influencing any drug company.
  • Regulators say Shkreli traded at least 60 drug stocks and livestreamed commentary on YouTube, X and Reddit.
  • The FTC reports Shkreli ran a $10 million 2022 account buying 11 pharma stocks, including Pfizer and Moderna.